Titre : Neurostimulation électrique transcutanée

Neurostimulation électrique transcutanée : Questions médicales fréquentes

Termes MeSH sélectionnés :

Disorders of Excessive Somnolence
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Neurostimulation électrique transcutanée : Questions médicales les plus fréquentes", "headline": "Neurostimulation électrique transcutanée : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Neurostimulation électrique transcutanée : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-08-04", "dateModified": "2025-05-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Neurostimulation électrique transcutanée" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Analgésie", "url": "https://questionsmedicales.fr/mesh/D000698", "about": { "@type": "MedicalCondition", "name": "Analgésie", "code": { "@type": "MedicalCode", "code": "D000698", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E03.091" } } }, "about": { "@type": "MedicalCondition", "name": "Neurostimulation électrique transcutanée", "alternateName": "Transcutaneous Electric Nerve Stimulation", "code": { "@type": "MedicalCode", "code": "D004561", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Carol G T Vance", "url": "https://questionsmedicales.fr/author/Carol%20G%20T%20Vance", "affiliation": { "@type": "Organization", "name": "Department of Physical Therapy and Rehabilitation Science, University of Iowa, Iowa City, Iowa." } }, { "@type": "Person", "name": "Hwi-Young Cho", "url": "https://questionsmedicales.fr/author/Hwi-Young%20Cho", "affiliation": { "@type": "Organization", "name": "Department of Physical Therapy, Gachon University, Incheon, Republic of Korea." } }, { "@type": "Person", "name": "Dana L Dailey", "url": "https://questionsmedicales.fr/author/Dana%20L%20Dailey", "affiliation": { "@type": "Organization", "name": "Department of Physical Therapy and Rehabilitation Science, University of Iowa, Iowa City, Iowa; Department of Physical Therapy St. Ambrose University, Davenport, Iowa. Electronic address: dana-dailey@uiowa.edu." } }, { "@type": "Person", "name": "Barbara A Rakel", "url": "https://questionsmedicales.fr/author/Barbara%20A%20Rakel", "affiliation": { "@type": "Organization", "name": "Department of Physical Therapy and Rehabilitation Science, University of Iowa, Iowa City, Iowa; College of Nursing, University of Iowa, Iowa City, Iowa." } }, { "@type": "Person", "name": "Jon M Williams", "url": "https://questionsmedicales.fr/author/Jon%20M%20Williams", "affiliation": { "@type": "Organization", "name": "Department of Medicine/Rheumatology & Immunology, Vanderbilt University, Nashville, Tennessee." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Excessive daytime sleepiness, morning tiredness, and prognostic biomarkers in patients with chronic coronary syndrome.", "datePublished": "2023-09-23", "url": "https://questionsmedicales.fr/article/37748524", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijcard.2023.131395" } }, { "@type": "ScholarlyArticle", "name": "Health-related impact of illness associated with excessive daytime sleepiness in patients with obstructive sleep apnea.", "datePublished": "2023-05-02", "url": "https://questionsmedicales.fr/article/37129416", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/00325481.2023.2203623" } }, { "@type": "ScholarlyArticle", "name": "Solriamfetol treatment of excessive daytime sleepiness in participants with narcolepsy or obstructive sleep apnea with a history of depression.", "datePublished": "2022-08-20", "url": "https://questionsmedicales.fr/article/36070638", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jpsychires.2022.08.018" } }, { "@type": "ScholarlyArticle", "name": "Major depressive episode with insomnia and excessive daytime sleepiness: A more homogeneous and severe subtype of depression.", "datePublished": "2023-11-11", "url": "https://questionsmedicales.fr/article/37979319", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.psychres.2023.115603" } }, { "@type": "ScholarlyArticle", "name": "Recommendations for clinical management of excessive daytime sleepiness in obstructive sleep apnoea - A Delphi consensus study.", "datePublished": "2023-10-09", "url": "https://questionsmedicales.fr/article/37839271", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.sleep.2023.10.001" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Anesthésie et analgésie", "item": "https://questionsmedicales.fr/mesh/D000760" }, { "@type": "ListItem", "position": 3, "name": "Analgésie", "item": "https://questionsmedicales.fr/mesh/D000698" }, { "@type": "ListItem", "position": 4, "name": "Neurostimulation électrique transcutanée", "item": "https://questionsmedicales.fr/mesh/D004561" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Neurostimulation électrique transcutanée - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Neurostimulation électrique transcutanée", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Neurostimulation électrique transcutanée", "description": "Comment évaluer l'efficacité du TENS ?\nQuels tests précèdent l'utilisation du TENS ?\nLe TENS est-il adapté à tous les patients ?\nComment déterminer la zone à traiter avec le TENS ?\nLe TENS peut-il être utilisé pour tous types de douleur ?", "url": "https://questionsmedicales.fr/mesh/D004561?mesh_terms=Disorders+of+Excessive+Somnolence&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Neurostimulation électrique transcutanée", "description": "Quels symptômes le TENS peut-il soulager ?\nLe TENS provoque-t-il des effets secondaires ?\nLe TENS peut-il aggraver certains symptômes ?\nQuels signes indiquent que le TENS fonctionne ?\nLe TENS peut-il aider à la douleur post-opératoire ?", "url": "https://questionsmedicales.fr/mesh/D004561?mesh_terms=Disorders+of+Excessive+Somnolence&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Neurostimulation électrique transcutanée", "description": "Le TENS peut-il prévenir la douleur chronique ?\nComment intégrer le TENS dans un plan de prévention ?\nLe TENS est-il utile pour les sportifs ?\nLe TENS peut-il aider à prévenir les douleurs liées au stress ?\nLe TENS est-il recommandé pour les douleurs de croissance chez les enfants ?", "url": "https://questionsmedicales.fr/mesh/D004561?mesh_terms=Disorders+of+Excessive+Somnolence&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Neurostimulation électrique transcutanée", "description": "Comment utiliser un appareil TENS ?\nQuelle est la durée recommandée d'utilisation du TENS ?\nLe TENS nécessite-t-il une prescription médicale ?\nPeut-on combiner le TENS avec d'autres traitements ?\nLe TENS est-il efficace pour les douleurs neuropathiques ?", "url": "https://questionsmedicales.fr/mesh/D004561?mesh_terms=Disorders+of+Excessive+Somnolence&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Neurostimulation électrique transcutanée", "description": "Quelles complications peuvent survenir avec le TENS ?\nLe TENS peut-il interférer avec d'autres traitements ?\nY a-t-il des risques d'accoutumance au TENS ?\nLe TENS peut-il causer des douleurs musculaires ?\nLe TENS est-il sûr pour les femmes enceintes ?", "url": "https://questionsmedicales.fr/mesh/D004561?mesh_terms=Disorders+of+Excessive+Somnolence&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Neurostimulation électrique transcutanée", "description": "Quels facteurs augmentent le besoin de TENS ?\nLes personnes âgées bénéficient-elles du TENS ?\nLe TENS est-il plus efficace chez certains groupes ?\nLes antécédents médicaux influencent-ils l'utilisation du TENS ?\nLe mode de vie affecte-t-il l'efficacité du TENS ?", "url": "https://questionsmedicales.fr/mesh/D004561?mesh_terms=Disorders+of+Excessive+Somnolence&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer l'efficacité du TENS ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité du TENS est évaluée par la réduction de la douleur et l'amélioration de la fonction." } }, { "@type": "Question", "name": "Quels tests précèdent l'utilisation du TENS ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests d'évaluation de la douleur et des antécédents médicaux sont réalisés avant le TENS." } }, { "@type": "Question", "name": "Le TENS est-il adapté à tous les patients ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, le TENS n'est pas recommandé pour les patients avec des pacemakers ou certaines conditions médicales." } }, { "@type": "Question", "name": "Comment déterminer la zone à traiter avec le TENS ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "La zone à traiter est déterminée en fonction de la localisation de la douleur et des symptômes." } }, { "@type": "Question", "name": "Le TENS peut-il être utilisé pour tous types de douleur ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Le TENS est efficace pour certaines douleurs chroniques, mais pas pour toutes les douleurs aiguës." } }, { "@type": "Question", "name": "Quels symptômes le TENS peut-il soulager ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Le TENS peut soulager des symptômes tels que la douleur chronique, les douleurs musculaires et articulaires." } }, { "@type": "Question", "name": "Le TENS provoque-t-il des effets secondaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des effets secondaires comme des irritations cutanées peuvent survenir, mais sont généralement légers." } }, { "@type": "Question", "name": "Le TENS peut-il aggraver certains symptômes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Dans de rares cas, le TENS peut aggraver la douleur ou provoquer des spasmes musculaires." } }, { "@type": "Question", "name": "Quels signes indiquent que le TENS fonctionne ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Une diminution de la douleur et une amélioration de la mobilité sont des signes de succès du TENS." } }, { "@type": "Question", "name": "Le TENS peut-il aider à la douleur post-opératoire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le TENS est souvent utilisé pour gérer la douleur post-opératoire et améliorer le confort." } }, { "@type": "Question", "name": "Le TENS peut-il prévenir la douleur chronique ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Le TENS peut aider à gérer la douleur, mais il n'est pas prouvé qu'il prévient la douleur chronique." } }, { "@type": "Question", "name": "Comment intégrer le TENS dans un plan de prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Le TENS peut être intégré dans un plan de gestion de la douleur avec des exercices et des thérapies." } }, { "@type": "Question", "name": "Le TENS est-il utile pour les sportifs ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les sportifs utilisent le TENS pour soulager les douleurs musculaires et favoriser la récupération." } }, { "@type": "Question", "name": "Le TENS peut-il aider à prévenir les douleurs liées au stress ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Le TENS peut réduire la tension musculaire liée au stress, mais ne prévient pas directement la douleur." } }, { "@type": "Question", "name": "Le TENS est-il recommandé pour les douleurs de croissance chez les enfants ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Le TENS peut être utilisé pour soulager les douleurs de croissance, mais sous supervision médicale." } }, { "@type": "Question", "name": "Comment utiliser un appareil TENS ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "L'appareil TENS est placé sur la peau, les électrodes sont positionnées sur la zone douloureuse." } }, { "@type": "Question", "name": "Quelle est la durée recommandée d'utilisation du TENS ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La durée recommandée est généralement de 20 à 30 minutes, plusieurs fois par jour." } }, { "@type": "Question", "name": "Le TENS nécessite-t-il une prescription médicale ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le TENS peut être utilisé sans prescription, mais il est conseillé de consulter un professionnel." } }, { "@type": "Question", "name": "Peut-on combiner le TENS avec d'autres traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le TENS peut être combiné avec des médicaments ou d'autres thérapies pour un meilleur effet." } }, { "@type": "Question", "name": "Le TENS est-il efficace pour les douleurs neuropathiques ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Le TENS peut être efficace pour certaines douleurs neuropathiques, mais les résultats varient." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le TENS ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des irritations cutanées, des brûlures légères ou des douleurs accrues." } }, { "@type": "Question", "name": "Le TENS peut-il interférer avec d'autres traitements ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Le TENS peut interférer avec certains dispositifs médicaux, comme les pacemakers, à éviter." } }, { "@type": "Question", "name": "Y a-t-il des risques d'accoutumance au TENS ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Il n'y a pas de preuve d'accoutumance au TENS, mais son efficacité peut diminuer avec le temps." } }, { "@type": "Question", "name": "Le TENS peut-il causer des douleurs musculaires ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, le TENS peut provoquer des douleurs musculaires temporaires après utilisation." } }, { "@type": "Question", "name": "Le TENS est-il sûr pour les femmes enceintes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Le TENS est généralement considéré comme sûr, mais il est conseillé de consulter un médecin." } }, { "@type": "Question", "name": "Quels facteurs augmentent le besoin de TENS ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des douleurs chroniques, des blessures sportives et des conditions médicales." } }, { "@type": "Question", "name": "Les personnes âgées bénéficient-elles du TENS ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent bénéficier du TENS pour soulager les douleurs liées à l'âge." } }, { "@type": "Question", "name": "Le TENS est-il plus efficace chez certains groupes ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Le TENS peut être plus efficace chez les personnes ayant des douleurs musculaires plutôt que nerveuses." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils l'utilisation du TENS ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies cardiaques ou neurologiques peuvent influencer son utilisation." } }, { "@type": "Question", "name": "Le mode de vie affecte-t-il l'efficacité du TENS ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie actif peut améliorer l'efficacité du TENS en réduisant la douleur et la tension." } } ] } ] }

Sources (10000 au total)

Excessive daytime sleepiness, morning tiredness, and prognostic biomarkers in patients with chronic coronary syndrome.

Sleep-related breathing disorders (SRBD) are related to cardiovascular outcomes in patients with chronic coronary syndrome (CCS). Whether SRBD-related symptoms are associated with prognostic biomarker... Associations between frequency (never/rarely, sometimes, often, always) of self-reported SRBD-related symptoms (excessive daytime sleepiness [EDS]; morning tiredness [MT]; loud snoring; multiple awake... EDS was associated (geometric mean ratio, 95% confidence interval) with increased levels of IL-6 (often 1.07 [1.03-1.10], always 1.15 [1.10-1.21]), GDF-15 (often 1.03 [1.01-1.06], always 1.07 [1.03-1.... In patients with CCS, stepwise increased frequency of SRBD-related symptoms, such as EDS and MT, were associated with gradually higher levels of IL-6 and GDF-15, each reflecting distinct pathophysiolo...

Health-related impact of illness associated with excessive daytime sleepiness in patients with obstructive sleep apnea.

This real-world study aimed to characterize the impact of illness of excessive daytime sleepiness (EDS) in patients with obstructive sleep apnea (OSA) who are adherent to continuous positive airway pr... This cross-sectional study surveyed participants in Evidation Health's Achievement app (November 2020-January 2021), a mobile consumer platform that encourages users to develop healthy habits and prov... In total, 476 participants (female,... EDS influences choices related to physical activity, caffeine consumption, and diet in patients who are adherent with CPAP. More research is needed to understand the association between EDS and choice...

Solriamfetol treatment of excessive daytime sleepiness in participants with narcolepsy or obstructive sleep apnea with a history of depression.

Given the high rate of depression associated with narcolepsy or obstructive sleep apnea (OSA), this analysis compared effects of solriamfetol treatment of excessive daytime sleepiness (EDS) in partici...

Major depressive episode with insomnia and excessive daytime sleepiness: A more homogeneous and severe subtype of depression.

Previous studies have noted the crucial role of excessive daytime sleepiness (EDS) in the course of depressive illness, and more recently, a few studies documented its strong associations with an incr...

Recommendations for clinical management of excessive daytime sleepiness in obstructive sleep apnoea - A Delphi consensus study.

Excessive daytime sleepiness is common with obstructive sleep apnoea and can persist despite efforts to optimise primary airway therapy. The literature lacks recommendations regarding differential dia... A panel of 10 international experts was convened to undertake a modified Delphi process. Statements were developed based on available evidence identified through a scoping literature review, and exper... Consensus was achieved for 32 final statements. The panel agreed excessive daytime sleepiness is a patient-reported symptom. The importance of subjective/objective evaluation of excessive daytime slee... Excessive daytime sleepiness in patients with obstructive sleep apnoea is a public health issue requiring increased awareness, recognition, and attention. Implementation of these statements may improv...

Effects of solriamfetol on on-the-road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea.

To evaluate the impact of solriamfetol, a dopamine and norepinephrine reuptake inhibitor, on on-the-road driving in participants with excessive daytime sleepiness (EDS) associated with obstructive sle... Eligible participants were aged 21-75 years with OSA and EDS (Maintenance of Wakefulness Test mean sleep latency <30 minutes and Epworth Sleepiness Scale score ≥10). Participants were randomised 1:1 t... Solriamfetol significantly reduced SDLP at 2 (n = 34; least squares mean difference, -1.1 cm; 95% CI, -1.85, -0.32; p = 0.006) and 6 hours postdose (n = 32; least squares mean difference, -0.8 cm; 95%... Solriamfetol 300 mg/day significantly improved on-the-road driving performance in participants with EDS associated with OSA....

Prevalence, dimensions, and correlates of excessive daytime sleepiness in community-dwelling older adults: the Yilan study, Taiwan.

Daytime sleepiness is an important health problem. However, the dimensionality of the Epworth Sleepiness Scale (ESS) in older adults remains unclear. This study aimed to determine the prevalence of ES... This is a community-based survey in which community-dwelling older adults aged ≥ 65 years participated. Excessive daytime sleepiness was assessed using the ESS and was defined as an ESS score of > 10.... In total, 3978 older adults participated in this study. The mean age was 76.6 ± 6.7 years, with 53.8% ≥ 75 years, and 57.1% were female. The prevalence of ESS-defined excessive daytime sleepiness was ... The prevalence of ESS-defined excessive daytime sleepiness is high, and its correlates vary among older adults. This study also suggests a dual ESS structure in community-dwelling older adults....

Calcium, magnesium, potassium, and sodium oxybates oral solution for cataplexy or excessive daytime sleepiness associated with narcolepsy.

Lower-sodium oxybate (LXB) is a novel formulation that is approved by the US Food and Drug Administration (FDA) to treat cataplexy and excessive daytime sleepiness (EDS) in adult patients and children... This drug review discusses narcolepsy, current and upcoming pharmacotherapy, and LXB chemistry, pharmacodynamics, pharmacokinetics, and metabolism. Published results from LXB's phase 1 studies, a phas... LXB is efficacious in treating daytime sleepiness and cataplexy in adults and children ≥7 years with narcolepsy. Using LXB instead of SXB formulations may benefit narcolepsy patients with cardiovascul...

The prevalence and predictors of poor sleep quality and excessive daytime sleepiness in epilepsy: A single tertiary centre experience in Malaysia.

People with epilepsy frequently encounter sleep disruptions that can stem from a variety of complex factors. Epilepsy-related sleep disturbance can lead to reduced quality of life and excessive daytim... A cross-sectional study on 284 epilepsy patients was performed in a local tertiary centre. The demographic and clinical epilepsy data were collected. The Pittsburgh Sleep Quality Index (PSQI) and Epwo... Poor sleep quality was reported in 78 (27.5%) patients while daytime hypersomnolence was present in 17 (6%) patients. The predictors of poor sleep quality include structural causes (OR = 2.749; 95% CI... Sleep disturbances frequently coexist with epilepsy. Patients should be actively evaluated using the PSQI and ESS questionnaires. It is imperative to identify the key factors that lead to reduced slee...